The effects of intravenous naltrindole and naltrindole 5'-isothiocyanate on sufentanil-induced respiratory depression and antinociception in rats

Pharmacology Biochemistry and Behavior

Volumn 63, Issue 1, 1999, Pages 175-183

  Verborgh, Christian ^a   Meert, Theo F ^b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Antinociception; Naltrindole; Naltrinole 5' isothiocyanate; Respiratory depression; Sufentanil

Indexed keywords

DELTA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTRINDOLE; NALTRINDOLE 5' ISOTHIOCYANATE; RECEPTOR SUBTYPE; SUFENTANIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BLOOD PH; CONTROLLED STUDY; HYPERCAPNIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; OXYGEN SATURATION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; ANOXIA; DEPRESSION, CHEMICAL; HYDROGEN-ION CONCENTRATION; HYPERCAPNIA; ISOTHIOCYANATES; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, OPIOID, MU; RESPIRATION; SUFENTANIL;

RATTUS NORVEGICUS;

EID: 0033004399     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00238-X     Document Type: Article

References (60)

1. Abdelhamid E.E., Sultana M., Portoghese P.S., Takemori A.E. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther. 258:1991;299-303.
2. Adams J.U., Geller E.B., Adler M.W. Receptor selectivity of icv morphine in the rat cold water tail-flick test. Drug Alcohol Depend. 35:1994;197-202.
3. Adams J.U., Tallarida R.J., Geller E.B., Adler M.W. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used. J. Pharmacol. Exp. Ther. 266:1993;1261-1267.
4. Baker M.L., Brockunier L.L., Bagley J.R., France C.P., Carr D.J. Fentanyl-related 4-heteroanilido piperidine OHM3295 augments splenic natural killer activity and induces analgesia through opioid receptor pathways. J. Pharmacol. Exp. Ther. 274:1995;1285-1292.
5. Bodnar R.J., Williams C.L., Lee S.J., Pasternak G.W. Role of mu 1-opiate receptors in supraspinal opiate analgesia. A microinjection study Brain Res. 447:1988;25-34.
6. Calcagnetti D.J., Fleetwood S.W., Holtzman S.G. Pharmacological profile of the potentiation of opioid analgesia by restraint stress. Pharmacol. Biochem. Behav. 37:1990;193-199.
7. Calcagnetti D.J., Helmstetter F.J., Fanselow M.S. Analgesia produced by centrally administered DAGO, DPDPE and U50488H in the formalin test. Eur. J. Pharmacol. 153:1988;117-122.
8. Calcagnetti D.J., Holtzman S.G. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine. Pharmacol. Biochem. Behav. 38:1991;185-190.
9. Emmerson P.J., Liu M.R., Woods J.H., Medzihradsky F. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J. Pharmacol. Exp. Ther. 271:1994;1630-1637.
10. Erspamer V., Melchiorri P., Falconieri-Erspamer G., Negri L., Corsi R., Severini C., Barra D., Simmaco M., Kreil G. Deltorphins. A family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites Proc. Natl. Acad. Sci. USA. 86:1989;5188-5192.
11. Feuerstein G., Zerbe R.L., Faden A.I. Opiate receptors and cardiovascular control in conscious SHR and WKY rats. Hypertension. 5:1983;663-671.
12. France C.P., de Costa B.R., Jacobson A.E., Rice K.C., Woods J.H. Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone. J. Pharmacol. Exp. Ther. 252:1990;600-604.
13. Frederickson R.C., Smithwick E.L., Shuman R., Bemis K.G. Metkephamid, a systemically active analog of methionine enkephalin with potent opioid alpha-receptor activity. Science. 211:1981;603-605.
14. Freye E., Latasch L., Portoghese P.S. The delta receptor is involved in sufentanil-induced respiratory depression; Opioid subreceptors mediate different effects. Eur. J. Anaesthesiol. 9:1992;457-462.
15. Hassen A.H., Feuerstein G., Faden A.I. Selective cardiorespiratory effects mediated by mu opioid receptors in the nucleus ambiguus. Neuropharmacology. 23:1984;407-415.
16. Hepburn M.J., Little P.J., Gingras J., Kuhn C.M. Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats. J. Pharmacol. Exp. Ther. 281:1997;1350-1356.
17. Heyman J.S., Jiang Q., Rothman R.B., Mosberg H.I., Porreca F. Modulation of mu-mediated antinociception by delta agonists. characterization with antagonists Eur. J. Pharmacol. 169:1989;43-52.
18. Heyman J.S., Vaught J.L., Mosberg H.I., Haaseth R.C., Porreca F. Modulation of μ-mediated antinociception by δ agonists in the mouse. Selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin Eur. J. Pharmacol. 165:1989;1-10.
19. Hurle M.A., Mediavilla A., Florez J. Differential respiratory patterns induced by opioids applied to the ventral medullary and dorsal pontine surfaces of cats. Neuropharmacology. 24:1985;597-606.
20. Hynes M.D., Frederickson R.C. Cross-tolerance studies distinguish morphine- and metkephamid-induced analgesia. Life Sci. 31:1982;1201-1204.
21. Jiang Q., Mosberg H.I., Porreca F. Selective modulation of morphine antinociception, but not development of tolerance, by δ receptor agonists. Eur. J. Pharmacol. 186:1990;137-141.
22. Jiang Q., Takemori A.E., Sultana M., Portoghese P.S., Bowen W.D., Mosberg H.I., Porreca F. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5′-isothiocyanate. Evidence for delta receptor subtypes J. Pharmacol. Exp. Ther. 257:1991;1069-1075.
23. Kiefel J.M., Rossi G.C., Bodnar R.J. Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624:1993;151-161.
24. Latasch L., Freye E. Opioid receptors-mediated respiratory effects and antinociception after S(+)-ketamine. Acta Anaesthesiol. Belg. 44:1993;93-102.
25. 3H]Sufentanil, a superior ligand for mu-opiate receptors. Binding properties and regional distribution in rat brain and spinal cord Eur. J. Pharmacol. 87:1983;209-225.
26. Li S.J., Zhang X., Ingenito A.J. Depressor and bradycardic effects induced by spinal subarachnoid injection of [D-Ala2-D-Leu5]enkephalin in rats. Neuropeptides. 12:1988;81-88.
27. Lord J.A., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides. multiple agonists and receptors Nature. 267:1977;495-499.
28. 3H]-lofentanil binding to opiate receptors in different cultured neuronal cells. Naunyn Schmiedebergs Arch. Pharmacol. 339:1989;192-199.
29. Mattia A., Vanderah T., Mosberg H.I., Porreca F. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice. Evidence for delta receptor subtypes J. Pharmacol. Exp. Ther. 258:1991;583-587.
30. May C.N., Dashwood M.R., Whitehead C.J., Mathias C.J. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits. Correlation with receptor distribution Br. J. Pharmacol. 98:1989;903-913.
31. Mayfield K.P., D'Alecy L.G. Delta-1 opioid receptor dependence of acute hypoxic adaptation. J. Pharmacol. Exp. Ther. 268:1994;74-77.
32. Miaskowski C., Taiwo Y.O., Levine J.D. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat. Eur. J. Pharmacol. 205:1991;247-252.
33. Miyamoto Y., Bowen W.D., Portoghese P.S., Takemori A.E. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice. J. Pharmacol. Exp. Ther. 270:1994;37-39.
34. Miyamoto Y., Portoghese P.S., Takemori A.E. Involvement of delta 2 opioid receptors in acute dependence on morphine in mice. J. Pharmacol. Exp. Ther. 265:1993;1325-1327.
35. Miyamoto Y., Portoghese P.S., Takemori A.E. Involvement of delta 2 opioid receptors in the development of morphine dependence in mice. J. Pharmacol. Exp. Ther. 264:1993;1141-1145.
36. Mosberg H.I., Hurst R., Hruby V.J., Gee K., Yamamura H.I., Galligan J.J., Burks T.F. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc. Natl. Acad. Sci. USA. 80:1983;5871-5874.
37. Negri L., Potenza R.L., Corsi R., Melchiorri P. Evidence for two subtypes of delta opioid receptors in rat brain. Eur. J. Pharmacol. 196:1991;335-336.
38. Negus S.S., Butelman E.R., Chang K.J., De Costa B., Winger G., Woods J.H. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. J. Pharmacol. Exp. Ther. 270:1994;1025-1034.
39. Ossipov M.H., Kovelowski C.J., Nichols M.L., Hruby V.J., Porreca F. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat. Pain. 62:1995;287-293.
40. Pasternak G.W. Multiple morphine and enkephalin receptors. Biochemical and pharmacological aspects Ann. NY Acad. Sci. 467:1986;130-139.
41. Pazos A., Florez J. A comparative study in rats of the respiratory depression and analgesia induced by mu- and delta-opioid agonists. Eur. J. Pharmacol. 99:1984;15-21.
42. Pfeiffer A., Feuerstein G., Kopin I.J., Faden A.I. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats. J. Pharmacol. Exp. Ther. 225:1983;735-741.
43. Porreca F., Takemori A.E., Sultana M., Portoghese P.S., Bowen W.D., Mosberg H.I. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J. Pharmacol. Exp. Ther. 263:1992;1447-1452.
44. Portoghese P.S., Sultana M., Nagase H., Takemori A.E. A highly selective delta 1-opioid receptor antagonist. 7-benzylidenenaltrexone Eur. J. Pharmacol. 218:1992;195-196.
45. Portoghese P.S., Sultana M., Takemori A.E. Naltrindole 5′-isothiocyanate. A nonequilibrium, highly selective delta opioid receptor antagonist J. Med. Chem. 33:1990;1547-1548.
46. Portoghese P.S., Sultana M., Takemori A.E. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur. J. Pharmacol. 146:1988;185-186.
47. Rady J.J., Takemori A.E., Portoghese P.S., Fujimoto J.M. Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss Webster mice. Life Sci. 55:1994;603-609.
48. Rodriguez-Diaz M., Garzon J., Sanchez-Blazquez P. The delta2-opioid receptor subtype stimulates phosphoinositide metabolism in mouse periaqueductal gray matter. Life Sci. 62:1998;PL253-PL258.
49. Rossi G.C., Pasternak G.W., Bodnar R.J. Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla. Brain Res. 665:1994;85-93.
50. Schaeffer J.I., Haddad G.G. Regulation of ventilation and oxygen consumption by delta- and mu-opioid receptor agonists. J. Appl. Physiol. 59:1985;959-968.
51. Shook J.E., Pelton J.T., Lemcke P.K., Porreca F., Hruby V.J., Burks T.F. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo. Identification of mu receptor-related functions J. Pharmacol. Exp. Ther. 242:1987;1-7.
52. Sofuoglu M., Portoghese P.S., Takemori A.E. 7-Benzylidenenaltrexone (BNTX). A selective δ-1 opioid receptor antagonist in the mouse spinal cord Life Sci. 52:1993;769-775.
53. Sofuoglu M., Portoghese P.S., Takemori A.E. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice. Evidence for delta opioid receptor subtypes J. Pharmacol. Exp. Ther. 257:1991;676-680.
54. Stewart P.E., Holper E.M., Hammond D.L. Delta antagonist and kappa agonist activity of Naltriben. Evidence for differential kappa interaction with the delta 1 and delta 2 opioid receptor subtypes Life Sci. 55:1994;PL79-PL84.
55. Suzuki T., Tsuji M., Mori T., Misawa M., Endoh T., Nagase H. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice. Life Sci. 57:1995;155-168.
56. Takemori A.E., Sultana M., Nagase H., Portoghese P.S. Agonist and antagonist activities of ligands derived from naltrexone and oxymorphone. Life Sci. 50:1992;1491-1495.
57. Thorat S.N., Hammond D.L. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat. J. Pharmacol. Exp. Ther. 283:1997;1185-1192.
58. Vanderah T.W., Wild K.D., Takemori A.E., Sultana M., Portoghese P.S., Bowen W.D., Mosberg H.I., Porreca F. Mediation of swim-stress antinociception by the opioid delta 2 receptor in the mouse. J. Pharmacol. Exp. Ther. 262:1992;190-197.
59. Vankova M.E., Weinger M.B., Chen D.Y., Bronson J.B., Motis V., Koob G.F. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat. Anesthesiology. 85:1996;574-583.
60. Vaught J.L., Rothman R.B., Westfall T.C. Mu and delta receptors. Their role in analgesia in the differential effects of opioid peptides on analgesia Life Sci. 30:1982;1443-1455.